{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:57:03Z","timestamp":1790751423882,"version":"4.1.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To systematically appraise the reporting completeness, methodological quality, risk of bias, and certainty of evidence for a prespecified outcome in systematic reviews and meta-analyses evaluating traditional Chinese medicine (TCM), either alone or in combination with conventional Western medicine, for acute upper respiratory tract infection (AURI) in children using an umbrella review approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Embase, Web of Science, the Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang Data, VIP Database, and the Chinese Biomedical Literature Database (SinoMed) were systematically searched from database inception to February 5, 2026, without restrictions on publication year. Systematic reviews and meta-analyses evaluating TCM alone or TCM combined with conventional Western medicine for pediatric AURI were eligible for inclusion. Reporting completeness was assessed using the PRISMA 2020 statement, methodological quality using AMSTAR 2, and risk of bias using ROBIS. In addition, the certainty of evidence for the outcome of total effective rate was independently reassessed for each included systematic review using the GRADE framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 41 systematic reviews and meta-analyses involving 57,590 children were included. The eligible reviews were published between 2010 and 2024; no systematic review or meta-analysis published between 2025 and February 5, 2026 met the prespecified eligibility criteria. Assessment against PRISMA 2020 identified varying degrees of underreporting, particularly with respect to protocol registration, complete search strategies, the influence of risk of bias on interpretation of findings, sensitivity analyses, and funding sources. According to AMSTAR 2, 37 reviews were rated as having moderate methodological quality, three as low quality, and one as critically low quality. ROBIS identified 38 reviews as being at high risk of bias. Across the 41 review-specific GRADE assessments of total effective rate, one was rated as moderate-certainty evidence, four as low-certainty evidence, and 36 as very-low-certainty evidence. These ratings apply exclusively to total effective rate, a non-standardized composite outcome, and should not be extrapolated to other outcomes such as time to fever resolution, duration of cough, or adverse events. Although most existing reviews suggested that TCM, either alone or combined with conventional Western medicine, may provide potential benefits in terms of total effective rate and selected short-term symptom outcomes, substantial clinical heterogeneity and methodological limitations were evident across the evidence base.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Existing systematic reviews suggest that TCM, either alone or in combination with conventional Western medicine, may offer potential clinical benefits for children with AURI. However, the overall evidence base is characterized by a high risk of bias, and the certainty of evidence for total effective rate\u2014a non-standardized composite outcome\u2014is predominantly low or very low. The available evidence is therefore insufficient to support strong clinical recommendations, and the findings should be interpreted cautiously. Future studies should prioritize standardized, clinically meaningful, patient-relevant outcomes and strengthen the rigorous evaluation of both efficacy and safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1896116","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:06:45Z","timestamp":1790748405000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evidence quality assessment of traditional Chinese medicine and integrated traditional Chinese and Western medicine for acute upper respiratory infection in children: an umbrella review of systematic reviews and meta-analyses"],"prefix":"10.3389","volume":"14","author":[{"given":"Zhen","family":"Liu","sequence":"first","affiliation":[{"name":"School of Second Clinical Medicine, Liaoning University of Traditional Chinese, Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Yang","sequence":"additional","affiliation":[{"name":"Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuetong","family":"Liu","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Lin","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongkai","family":"Wang","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyang","family":"Shi","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqi","family":"Wu","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1086\/528685","article-title":"Viral upper respiratory tract infection and otitis media complication in young children","volume":"46","author":"Chonmaitree","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1038\/s41467-019-10294-x","article-title":"Altered respiratory virome and serum cytokine profile associated with recurrent respiratory tract infections in children","volume":"10","author":"Li","year":"2019","journal-title":"Nat Commun"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1038\/s41467-021-25120-6","article-title":"Etiological and epidemiological features of acute respiratory infections in China","volume":"12","author":"Li","year":"2021","journal-title":"Nat Commun"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e2214153","DOI":"10.1001\/jamanetworkopen.2022.14153","article-title":"Association of inappropriate outpatient pediatric antibiotic prescriptions with adverse drug events and health care expenditures","volume":"5","author":"Butler","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S0254-6272(18)30882-3","article-title":"Clinical practices s of traditional Chinese medicine for acute upper respiratory tract infection in children","volume":"38","author":"Ping","year":"2018","journal-title":"J Tradit Chin Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/13880209.2022.2074053","article-title":"Research progress on antiviral constituents in traditional Chinese medicines and their mechanisms of action","volume":"60","author":"Chen","year":"2022","journal-title":"Pharm Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e000604","DOI":"10.1136\/bmjmed-2023-000604","article-title":"Assessing the methodological quality and risk of bias of systematic reviews: primer for authors of overviews of systematic reviews","volume":"3","author":"Lunny","year":"2024","journal-title":"BMJ Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"B10","volume-title":"Zhu Futang Textbook of Pediatrics. 8th edn","author":"Jiang","year":"2015"},{"key":"B11","first-page":"997","volume-title":"Pediatrics","author":"Huang","year":"2022"},{"key":"B12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jclinepi.2019.05.028","article-title":"A psychometric study found AMSTAR 2 to be a valid and moderately reliable appraisal tool","volume":"114","author":"Lorenz","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13643-020-01509-0","article-title":"Guidance for overviews of reviews continues to accumulate, but important challenges remain: a scoping review","volume":"9","author":"Gates","year":"2020","journal-title":"Syst Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jclinepi.2015.06.005","article-title":"ROBIS: a new tool to assess risk of bias in systematic reviews was developed","volume":"69","author":"Whiting","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"l2368","DOI":"10.1136\/bmj.l2368","article-title":"Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies","volume":"366","author":"Neuenschwander","year":"2019","journal-title":"Br Med J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"Br Med J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"m2980","DOI":"10.1136\/bmj.m2980","article-title":"Drug treatments for COVID-19: living systematic review and network meta-analysis","volume":"370","author":"Siemieniuk","year":"2020","journal-title":"Br Med J"},{"key":"B18","first-page":"314","article-title":"Meta-analysis of the efficacy of reduning in the treatment of upper respiratory tract infection","volume":"19","author":"Li","year":"2010","journal-title":"Chin J Pharmacoepidemiol"},{"key":"B19","first-page":"63","article-title":"Meta-analysis of reduning and xiyanping injections for acute upper respiratory tract infection","volume":"28","author":"Tao","year":"2015","journal-title":"West J Tradit Chin Med"},{"key":"B20","first-page":"278","article-title":"Meta-analysis of reduning versus ribavirin in the treatment of pediatric acute upper respiratory tract infection","volume":"38","author":"Guo","year":"2016","journal-title":"Chin Tradit Pat Med"},{"key":"B21","first-page":"821","article-title":"Meta-analysis of the efficacy of yanhuning versus ribavirin in the treatment of herpangina in children","volume":"22","author":"Wu","year":"2013","journal-title":"Mod J Integr Tradit Chin West Med"},{"key":"B22","first-page":"974","article-title":"Xiyanping versus ribavirin aerosol inhalation for respiratory tract infections in children: a meta-analysis of randomized controlled trials","volume":"11","author":"Shi","year":"2014","journal-title":"Int J Tradit Chin Med"},{"key":"B23","first-page":"337","article-title":"Meta-analysis of xiyanping versus ribavirin for pediatric herpangina","volume":"27","author":"Lian","year":"2016","journal-title":"China Pharmacy"},{"key":"B24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3969\/j.issn.1001-1528.2017.03.008","article-title":"Meta-analysis of the efficacy of xiyanping injection versus ribavirin in the treatment of pediatric acute upper respiratory tract infection","volume":"39","author":"Ren","year":"2017","journal-title":"Chin Tradit Pat Med"},{"key":"B25","first-page":"165","article-title":"Systematic review of the efficacy and safety of xiyanping injection for pediatric upper respiratory tract infection","volume":"33","author":"Liu","year":"2017","journal-title":"Pharm Clin Chin Mater Med"},{"key":"B26","first-page":"215","article-title":"Systematic review of Tanreqing Injection for pediatric upper respiratory tract infection","volume":"22","author":"Han","year":"2016","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"B27","first-page":"138","article-title":"Systematic review of two heat-clearing and detoxifying injections for pediatric upper respiratory tract infection","volume":"13","author":"Liu","year":"2017","journal-title":"Asia Pac Tradit Med"},{"key":"B28","first-page":"863","article-title":"Meta-analysis of the effectiveness of lanqin oral liquid in the treatment of pediatric upper respiratory tract infection","volume":"34","author":"Zhang","year":"2015","journal-title":"Beijing J Tradit Chin Med"},{"key":"B29","first-page":"89","article-title":"Meta-analysis of the clinical efficacy of xiaoer chiqiao qingre granules for acute upper respiratory tract infection","volume":"31","author":"Yuan","year":"2016","journal-title":"China J Tradit Chin Med Pharm"},{"key":"B30","first-page":"393","article-title":"Meta-analysis of jinlian qingre effervescent tablets for pediatric acute upper respiratory tract infection","volume":"40","author":"Zhong","year":"2017","journal-title":"Drug Eval Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0181780","DOI":"10.1371\/journal.pone.0169691","article-title":"Andrographis paniculata (Chu\u0101n X\u012bn Li\u00e1n) for symptomatic relief of acute respiratory tract infections in adults and children: a systematic review and meta-analysis","volume":"12","author":"Hu","year":"2017","journal-title":"PLoS One"},{"key":"B32","first-page":"177","article-title":"Meta-analysis of xiaoer chiqiao qingre granules versus ribavirin for pediatric acute upper respiratory tract infection","volume":"16","author":"Ma","year":"2020","journal-title":"Asia Pac Tradit Med"},{"key":"B33","first-page":"99","article-title":"Meta-analysis of reduning injection versus ribavirin for herpangina in children","volume":"18","author":"Fang","year":"2012","journal-title":"Guiding J Tradit Chin Med Pharm"},{"key":"B34","first-page":"195","article-title":"Meta-analysis of xiyanping combined with ribavirin for pediatric herpangina","volume":"22","author":"Xu","year":"2016","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"B35","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.eujim.2016.06.019","article-title":"Qingkailing injection for uncomplicated upper respiratory tract infection: a systematic review and meta-analysis","volume":"8","author":"Li","year":"2016","journal-title":"Eur J Integr Med"},{"key":"B36","first-page":"1035","article-title":"Systematic review of the efficacy and safety of Yanhuning Injection versus interferon-\u03b1 for pediatric upper respiratory tract infection","volume":"39","author":"Peng","year":"2019","journal-title":"J Hunan Univ Chin Med"},{"key":"B37","first-page":"1419","article-title":"Systematic review of Ganke Shuangqing Capsules for acute upper respiratory tract infection","volume":"22","author":"Luo","year":"2011","journal-title":"China Pharmacy"},{"key":"B38","first-page":"47","article-title":"Systematic review of xiaoer chiqiao qingre granules for pediatric upper respiratory tract infection","volume":"22","author":"Chen","year":"2013","journal-title":"China Pharmaceuticals"},{"key":"B39","first-page":"1540","article-title":"Meta-analysis of the safety and efficacy of kaihoujian spray combined with conventional therapy for herpetic oral diseases in children","volume":"29","author":"Tao","year":"2017","journal-title":"Med J West China"},{"key":"B40","first-page":"14","article-title":"Meta-analysis of the clinical efficacy of an\u2019erning granules for respiratory infections in children","volume":"48","author":"Rong","year":"2021","journal-title":"Liaoning J Tradit Chin Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"100726","DOI":"10.1016\/j.imr.2021.100726","article-title":"Chinese patent herbal medicine (Shufeng Jiedu Capsule) for acute upper respiratory tract infections: a systematic review and meta-analysis","volume":"10","author":"Zhang","year":"2021","journal-title":"Integr Med Res"},{"key":"B42","first-page":"3211","article-title":"Meta-analysis of shufeng jiedu capsule combined with western medicine for pediatric acute upper respiratory tract infection","volume":"18","author":"Wang","year":"2023","journal-title":"World Chin Med"},{"key":"B43","first-page":"19","article-title":"Systematic review of xiyanping combined with conventional treatment for pediatric herpangina","volume":"21","author":"Chen","year":"2012","journal-title":"China Pharmaceutics"},{"key":"B44","first-page":"83","article-title":"Meta-analysis of yanhuning in the treatment of pediatric acute upper respiratory tract infection","volume":"18","author":"Guo","year":"2016","journal-title":"J Liaoning Univ Tradit Chin Med"},{"key":"B45","first-page":"15","article-title":"Meta-analysis of randomized controlled trials of traditional Chinese medicine for fever in pediatric upper respiratory tract infection","volume":"30","author":"Qiu","year":"2014","journal-title":"J Nanjing Univ Tradit Chin Med"},{"key":"B46","first-page":"88","article-title":"Meta-analysis of traditional Chinese medicine in the treatment of herpangina in children","volume":"22","author":"Liu","year":"2016","journal-title":"Guiding J Tradit Chin Med Pharm"},{"key":"B47","first-page":"3","article-title":"Systematic review of the efficacy and safety of Lanqin Oral Liquid for upper respiratory tract infection in children","volume":"10","author":"Duan","year":"2016","journal-title":"Chin J Mod Drug Appl"},{"key":"B48","first-page":"1702","article-title":"Meta-analysis of the efficacy and safety of lanqin oral liquid for herpangina in children","volume":"30","author":"Yuan","year":"2019","journal-title":"China Pharmacy"},{"key":"B49","first-page":"72","article-title":"Meta-analysis of the clinical efficacy and safety of ribavirin alone versus combined with xiaoer chaigui tuire granules for pediatric acute upper respiratory tract infection","volume":"19","author":"Chen","year":"2018","journal-title":"Infect Inflamm Repair"},{"key":"B50","first-page":"1957","article-title":"Systematic review and meta-analysis of the efficacy and safety of xiaoer chaigui tuire granules for acute upper respiratory tract infection","volume":"22","author":"Li","year":"2024","journal-title":"Chin J Gen Pract"},{"key":"B51","first-page":"63","article-title":"Meta-analysis of shuanghuanglian oral liquid alone or combined with conventional therapy for pediatric acute upper respiratory tract infection","volume":"33","author":"Wang","year":"2019","journal-title":"Res Pract Chin Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.19540\/j.cnki.cjcmm.20200102.501","article-title":"Meta-analysis of the clinical efficacy and safety of Pudilan Xiaoyan Oral Liquid for pediatric upper respiratory tract infection","volume":"45","author":"Bai","year":"2020","journal-title":"China J Chin Mater Med"},{"key":"B53","first-page":"52","article-title":"Meta-analysis of Pudilan Xiaoyan Oral Liquid for pediatric herpangina","volume":"28","author":"Xu","year":"2020","journal-title":"China\u2019s Naturopathy"},{"key":"B54","first-page":"99","article-title":"Systematic review and meta-analysis of jian\u2019er qingjie liquid for upper respiratory tract infection in children","volume":"31","author":"Cai","year":"2022","journal-title":"Chin J Ethnomed Ethnopharm"},{"key":"B55","first-page":"33","article-title":"Meta-analysis of the clinical efficacy of Qinxiang Qingjie Oral Liquid for upper respiratory tract infection in children","volume":"9","author":"Zhu","year":"2022","journal-title":"Electron J Clin Med Lit"},{"key":"B56","first-page":"101","article-title":"Meta-analysis of the efficacy and safety of oral yinqiao powder for pediatric upper respiratory tract infection","volume":"32","author":"Shi","year":"2023","journal-title":"Chin J Ethnomed Ethnopharm"},{"key":"B57","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.19540\/j.cnki.cjcmm.20230605.501","article-title":"Meta-analysis and trial sequential analysis of Chaihuang Granules in the treatment of pediatric upper respiratory tract infection","volume":"48","author":"Zhong","year":"2023","journal-title":"China J Chin Mater Med"},{"key":"B58","first-page":"43","article-title":"Meta-analysis of the efficacy and safety of kanggan granules for pediatric upper respiratory tract infection","volume":"19","author":"Xu","year":"2024","journal-title":"China J Pharm Econ"},{"key":"B59","doi-asserted-by":"publisher","first-page":"c3920","DOI":"10.1136\/bmj.c3920","article-title":"Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review","volume":"341","author":"Cordoba","year":"2010","journal-title":"Br Med J"},{"key":"B60","doi-asserted-by":"publisher","first-page":"k3786","DOI":"10.1136\/bmj.k3786","article-title":"What treatments are effective for common cold in adults and children?","volume":"363","author":"Van Driel","year":"2018","journal-title":"Br Med J"},{"key":"B61","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4103\/0976-500X.72352","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"1","author":"Schulz","year":"2010","journal-title":"J Pharmacol Pharmacother"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e1002148","DOI":"10.1371\/journal.pmed.1002148","article-title":"Core outcome set-STAndards for reporting: the COS-STAR statement","volume":"13","author":"Kirkham","year":"2016","journal-title":"PLoS Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1896116\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:06:52Z","timestamp":1790748412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1896116\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":62,"alternative-id":["10.3389\/fped.2026.1896116"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1896116","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1896116"}}